Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Harmony Biosciences Holdings Inc (NQ: HRMY )

32.44 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 2, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 32.44
Bid (Size) 29.86 (3)
Ask (Size) 37.15 (1)
Prev. Close 32.44
Today's Range 32.44 - 32.44
52wk Range 29.81 - 62.09
Shares Outstanding 60,000,145
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Expert Ratings for Harmony Biosciences
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 25, 2023
Via Benzinga

Performance

YTD
-38.75%
-38.75%
1 Month
-7.89%
-7.89%
3 Month
-6.89%
-6.89%
6 Month
-2.26%
-2.26%
1 Year
-28.55%
-28.55%

More News

Read More
9 Analysts Have This to Say About Harmony Biosciences
Via Benzinga
Expert Ratings for Harmony Biosciences
Via Benzinga
The Latest Analyst Ratings for Harmony Biosciences
Via Benzinga
Harmony Biosciences's Earnings Outlook
Via Benzinga
Analyst Expectations for Harmony Biosciences's Future
Via Benzinga
Harmony Biosciences Earnings Perspective: Return On Capital Employed
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2023
Via Benzinga
ZYNERBA PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Zynerba Pharmaceuticals, Inc. - ZYNE
From Kahn Swick & Foti, LLC
Via Business Wire
Analyst Expectations for Harmony Biosciences's Future
Via Benzinga
NASDAQ: HRMY Investor Alert: Investigation over Potential Wrongdoing at Harmony Biosciences Holdings, Inc.
Via SBWire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Zynerba Pharmaceuticals, Inc. (Nasdaq - ZYNE), Chindata Group Holdings Limited (Nasdaq - CD), Capri Holdings Limited (NYSE – CPRI), Avid® (Nasdaq - AVID)
From Brodsky & Smith LLC
Via GlobeNewswire
Crude Oil Down 1%; Zynerba Pharmaceuticals Shares Spike Higher
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Why Is Zynerba Pharmaceuticals (ZYNE) Stock Up 270% Today?
Via InvestorPlace
Health Care Company Harmony Biosciences Announces Acquisition of Zynerba Pharmaceuticals
Via Benzinga
A Look Into Healthcare Sector Value Stocks
Via Benzinga
Why Zynerba Pharmaceuticals Stock Is Skyrocketing Today?
Via Benzinga
7 ‘Strong Buy’ Value Stocks You Should Be Loading Up On Now
Via InvestorPlace
Harmony Biosciences (HRMY) Q2 2023 Earnings Call Transcript
Via The Motley Fool
Harmony Biosciences Reports Second Quarter 2023 Financial Results and Business Updates
From Harmony Biosciences
Via GlobeNewswire
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
7 Best High-Growth Stocks to Buy if You’re a Young Investor
Via InvestorPlace
3 Biotech Stocks to Buy With Explosive Upside Potential
Via InvestorPlace
Bragar Eagel & Squire, P.C. Is Investigating Techtronic, Boxed, Coinbase, and Harmony and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.